Hester Biosciences has received an approval for issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 150 crore. The Board of Directors in their meeting held on December 18, 2019, approved the same.
Hester Biosciences is engaged in the manufacturing of poultry vaccines.